Prenatal Exposure to Macrolides and Risk of Congenital Malformations: A Meta-Analysis.
Narmeen MallahHamid Reza TohidinikMahyar EtminanAdolfo FigueirasBahi TakkouchePublished in: Drug safety (2020)
Our study suggests a weak association between prenatal use of macrolides and congenital malformations, limited to exposure in early pregnancy, and musculoskeletal and digestive systems. In addition to studies with a larger control of confounding, risk-benefit research is needed to determine the usefulness of macrolides during pregnancy.
Keyphrases